MAIA Biotechnology Inc —— 季度财务数据 (NYSE:MAIA)

Financials

经营活动产生的现金 -3.91 M-4.2 M-4.14 M-3.49 M-7.02 M -18.84 M 投资活动产生的现金 ————— — 融资活动产生的现金 4.85 M5.46 M3.41 M4.23 M4.8 M 17.91 M 自由现金流 -3.91 M-4.2 M-4.14 M-3.49 M-7.02 M -18.84 M

MAIA Biotechnology Inc

MAIA Biotechnology, Inc. is a public, immune-oncology company based in Chicago, IL focused on the development of telomere targeting agents for the treatment of telomerase-positive cancer cells.

新闻

MAIA Biotechnology股价因折价股票发行下跌29%

MAIA Biotechnology shares drop 29% on discounted stock offering

Stan Smith以每股1.224美元购入MAIA生物科技公司价值69,999美元股票

陆雅仪以99999美元购入MAIA Biotechnology (MAIA)股票

Chaouki Steven M以49999美元购买MAIA Biotechnology股票

迈亚生物科技CEO Vitoc Vlad购入价值1万美元股票

Maia生物科技CEO Vlad Vitoc购入价值$79,848的公司股票

Vitoc Vlad, CEO of Maia Biotechnology, buys $10k in shares

Vlad Vitoc, Maia Biotech CEO, buys $79,848 in Maia stock

Vitoc Vlad购买MAIA生物科技(MAIA)股票价值$79,848

Vitoc Vlad buys MAIA biotechnology (MAIA) shares worth $79,848

Maia Biotechnology董事Luput Cristian购入价值$41,845的股票